Rahel Frick

702 total citations
16 papers, 462 citations indexed

About

Rahel Frick is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Rahel Frick has authored 16 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Rahel Frick's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (4 papers) and Celiac Disease Research and Management (3 papers). Rahel Frick is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (4 papers) and Celiac Disease Research and Management (3 papers). Rahel Frick collaborates with scholars based in United States, Norway and Germany. Rahel Frick's co-authors include Jeffrey J. Gray, Jeliazko R. Jeliazkov, Roland L. Dunbrack, Jared Adolf‐Bryfogle, Daisuke Kuroda, Brian D. Weitzner, Sergey Lyskov, Nicholas Marze, Inger Sandlie and Lene S. Høydahl and has published in prestigious journals such as Gastroenterology, PLoS ONE and Nature Protocols.

In The Last Decade

Rahel Frick

16 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rahel Frick United States 11 261 251 144 70 63 16 462
Fiorenza Falcioni United States 11 143 0.5× 154 0.6× 393 2.7× 14 0.2× 63 1.0× 18 584
Nina Schmolka Portugal 11 34 0.1× 241 1.0× 383 2.7× 31 0.4× 38 0.6× 12 645
A. V. Kozyr Russia 10 304 1.2× 250 1.0× 183 1.3× 8 0.1× 15 0.2× 28 463
Nicholas J. Viner United States 9 135 0.5× 157 0.6× 430 3.0× 10 0.1× 26 0.4× 11 532
Jeff Lutman United States 8 373 1.4× 362 1.4× 213 1.5× 3 0.0× 47 0.7× 10 552
Anna Bulek United Kingdom 14 128 0.5× 168 0.7× 527 3.7× 8 0.1× 24 0.4× 17 652
А. Г. Габибов Russia 10 150 0.6× 160 0.6× 101 0.7× 5 0.1× 18 0.3× 30 332
Andrew Trimby United Kingdom 9 51 0.2× 165 0.7× 251 1.7× 10 0.1× 15 0.2× 9 391
Esther M. Yoo United States 10 224 0.9× 197 0.8× 158 1.1× 3 0.0× 43 0.7× 11 383
Navreet K. Nanda United States 9 89 0.3× 133 0.5× 317 2.2× 8 0.1× 29 0.5× 15 390

Countries citing papers authored by Rahel Frick

Since Specialization
Citations

This map shows the geographic impact of Rahel Frick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahel Frick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahel Frick more than expected).

Fields of papers citing papers by Rahel Frick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahel Frick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahel Frick. The network helps show where Rahel Frick may publish in the future.

Co-authorship network of co-authors of Rahel Frick

This figure shows the co-authorship network connecting the top 25 collaborators of Rahel Frick. A scholar is included among the top collaborators of Rahel Frick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahel Frick. Rahel Frick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Gjølberg, Torleif Tollefsrud, Rahel Frick, Stian Foss, et al.. (2022). Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life. Communications Biology. 5(1). 832–832. 14 indexed citations
3.
Grevys, Algirdas, Rahel Frick, Karine Flem‐Karlsen, et al.. (2022). Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life. iScience. 25(2). 103746–103746. 35 indexed citations
4.
Mahajan, Sai Pooja, Jeffrey A. Ruffolo, Rahel Frick, & Jeffrey J. Gray. (2022). Hallucinating structure-conditioned antibody libraries for target-specific binders. Frontiers in Immunology. 13. 999034–999034. 11 indexed citations
5.
Mahajan, Sai Pooja, Jeffrey A. Ruffolo, Rahel Frick, & Jeffrey J. Gray. (2022). Towards deep learning models for target-specific antibody design. Biophysical Journal. 121(3). 528a–528a. 1 indexed citations
6.
Chowdhury, Ratul, et al.. (2022). De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD ). Proteins Structure Function and Bioinformatics. 91(2). 196–208. 9 indexed citations
7.
Frick, Rahel, Lene S. Høydahl, Erik Sebastian Vik, et al.. (2022). Affinity maturation of TCR-like antibodies using phage display guided by structural modeling. Protein Engineering Design and Selection. 35. 2 indexed citations
8.
Frick, Rahel, Lene S. Høydahl, Jan Petersen, et al.. (2021). A high-affinity human TCR-like antibody detects celiac disease gluten peptide–MHC complexes and inhibits T cell activation. Science Immunology. 6(62). 18 indexed citations
9.
Jeliazkov, Jeliazko R., Rahel Frick, Jing Zhou, & Jeffrey J. Gray. (2021). Robustification of RosettaAntibody and Rosetta SnugDock. PLoS ONE. 16(3). e0234282–e0234282. 23 indexed citations
10.
Høydahl, Lene S., Rahel Frick, Inger Sandlie, & Geir Åge Løset. (2019). Targeting the MHC Ligandome by Use of TCR-Like Antibodies. Antibodies. 8(2). 32–32. 36 indexed citations
11.
Høydahl, Lene S., Lisa Richter, Rahel Frick, et al.. (2018). Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease. Gastroenterology. 156(5). 1428–1439.e10. 61 indexed citations
12.
Gunnarsen, Kristin Støen, Lene S. Høydahl, Louise F. Risnes, et al.. (2017). A TCRα framework–centered codon shapes a biased T cell repertoire through direct MHC and CDR3β interactions. JCI Insight. 2(17). 12 indexed citations
13.
Weitzner, Brian D., Jeliazko R. Jeliazkov, Sergey Lyskov, et al.. (2017). Modeling and docking of antibody structures with Rosetta. Nature Protocols. 12(2). 401–416. 199 indexed citations
14.
Arntzen, Magnus Ø., Paul Boddie, Rahel Frick, Christian Koehler, & Bernd Thiede. (2015). Consolidation of proteomics data in the Cancer Proteomics database. PROTEOMICS. 15(22). 3765–3771. 8 indexed citations
15.
Hayes, Kathleen, et al.. (1995). Early Suppression of Viremia by ZDV Does Not Alter the Spread of Feline Immunodeficiency Virus Infection in Cats. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 9(2). 114???122–114???122. 20 indexed citations
16.
Scheiffarth, F, H. Götz, & Rahel Frick. (1967). Agarelektrophoretische Studien zum Nachweis vonIsoenzymen der Lactatdehydrogenase in verschiedenen menschlichen Organextrakten. Enzymologia biologica et clinica. 8(4). 283–297. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026